文献速递泌尿与男性生殖病理

前列腺癌整体Gleason分级组:活检与根治标本的一致性及升级降级预测因素

Global Gleason grade groups in prostate cancer: concordance of biopsy and radical prostatectomy grades and predictors of upgrade and downgrade.
PubMed 文献 · Histopathology · 2017-03-28

研究评估2529例前列腺癌患者活检与根治标本的整体Gleason分级组(GR)一致性及升级降级相关因素。总体一致率59.3%,GR2和GR5一致性最高,GR4最低;GR1升级率52.4%,GR2降级率30.8%。GR1升级与年龄≥60岁、PSA密度≥0.2、≥2阳性针、≥5%组织受累及神经侵犯相关。

要点

  • 活检与根治标本GR总体一致率59.3%,GR2和GR5一致性最高,GR4最低。
  • 活检GR1升级至GR2最常见,升级率52.4%;活检GR2降级率30.8%。
  • GR1升级与年龄≥60岁、PSA密度≥0.2、≥2阳性针等相关。

核心结论

  • 活检与根治标本整体Gleason分级组一致率为59.3%,GR2和GR5一致性最高,GR4最低。
  • 活检GR1升级和GR2降级与基线临床变量相关,可能辅助临床决策。

研究设计与样本

  • 回顾性评估2005至2014年在本机构接受活检和前列腺切除术的2529例患者。
  • 采用整体分级组(GR)/Gleason评分(GS),通过多变量逻辑回归分析GR1/GS≤6升级和GR2/GS3+4降级相关因素。

主要发现

  • GR1-5一致率分别为47.6%、73.6%、52.8%、21.4%和68.3%。
  • 最终GR升级占32.3%,其中GR1-4升级率分别为52.4%、19.0%、16.4%和32.9%。
  • 最终GR降级占8.3%,GR2-5降级率分别为7.4%、30.8%、45.7%和31.7%。
  • GR1升级相关因素:年龄≥60岁、PSA密度≥0.2、≥2阳性针、≥5%核心组织受累、神经侵犯(ROC曲线下面积0.699)。
  • GR2降级与年龄≥60岁、PSA>10 ng/ml、≥2阳性针呈负相关(ROC曲线下面积0.623)。

临床怎么用

  • 活检GR1患者若存在年龄≥60岁、PSA密度≥0.2、≥2阳性针、≥5%组织受累或神经侵犯,升级风险较高,可考虑更积极评估。
  • 活检GR2患者若年龄<60岁、PSA≤10 ng/ml或<2阳性针,降级可能性较高,可辅助治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To evaluate concordance, upgrades and downgrades from biopsy to prostatectomy, and associated clincopathological parameters, using the recently proposed Gleason grade groups/International Society of Urologic Pathology (ISUP) grades. METHODS AND RESULTS: We evaluated 2529 patients who underwent biopsy and prostatectomy in our institution from 2005 to 2014. A global grade group (GR)/Gleason score (GS) was used. Factors associated with GR1/GS ≤6 upgrades and GR2/GS3 + 4 downgrades were analysed by multivariable logistic regression. The final GR/GS was identical with the biopsy GR/GS in 59.3% of cases, with the highest concordance for GR2 and GR5 and lowest for GR4. In GR1-5, identical grades were found in GR: (i) 47.6%, (ii) 73.6%, (iii) 52.8%, (iv) 21.4% and (v) 68.3%, respectively. Final GR was upgraded in 32.3% cases; in GR1-4: (i) 52.4%, (ii) 19.0%, (iii) 16.4% and (iv) 32.9%. Most frequent upgrades occurred from biopsy GR1 to prostatectomy GR2. A final GR downgrade was found in 8.3% cases. For individual GR2-5 the downgrades were found in GR: (i) 7.4%, (ii) 30.8%, (iii) 45.7% and (iv) 31.7%. Upgrades of biopsy GR1 were associated with: age ≥60 years, PSA density ≥0.2, ≥2 positive cores, ≥5% core tissue involvement and perineural invasion [area under receiver operating characteristic (ROC) curve 0.699]. Downgrades of biopsy GR2 correlated inversely with: age ≥60 years, PSA >10 ng/ml and ≥2 positive core (area under ROC curve 0.623). CONCLUSIONS: We found highest concordance for GR2 and GR5 and lowest for GR4. The baseline clinical variables associated with GR1 upgrades and GR2 downgrades may play a role in clinical decision-making.

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Athanazio D, Gotto G, Shea-Budgell M, et al. Global Gleason grade groups in prostate cancer: concordance of biopsy and radical prostatectomy grades and predictors of upgrade and downgrade. Histopathology. 2017. PMID: 28370140. doi:10.1111/his.13179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。